1. 1) Kozlov, M. V., Urnysheva, V. V., and Shishkina, L. N. (2008) Interconnection of parameters of regulation system of lipid peroxidation and of morphophysiological parameters of mouse liver. Zh. Evol. Biokhim. Fiziol. 44: 398–402.
2. 2) Grandhi, M. S., Kim, A. K., Ronnekleiv-Kelly, S. M., Kamel, I. R., Ghasebeh, M. A., and Pawlik, T. M. (2016) Hepatocellular carcinoma: From diagnosis to treatment. Surg. Oncol. 25: 74–85.
3. 3) Smithgall, T. E., Harvey, R. G., and Penning, T. M. (1988) Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3a-hydroxysteroid-dihydrodiol dehydrogenase: Effects of methyl substitution on velocity and stereochemica. Cancer Res. 48: 1227–1232.
4. 4) Digiovanni, J., and Juchau, M. R. (1980) Biotransformation and Bioactivation of 7,12-Dimethylbenz[a]anthracene (7,12-DMBA). Drug Metab. Rev. 11: 61–101.
5. 5) Muqbil, I., and Banu, N. (2006) Enhancement of pro-oxidant effect of 7,12-dimethylbenz (a) anthracene (DMBA) in rats by pre-exposure to restraint stress. Cancer Lett. 240: 213–220.